A New Litigation Landscape in The UK?
David Cameron Supports British Insurers Over Solvency II, LOL
The Rebirth of Mold Claims?
This month, Royal Assent was granted to the unpromisingly named “Legal Aid, Sentencing and Punishment of Offenders Act”. Although you would not guess it from the title, aspects of this new A... Continue reading →
It was no doubt a blessed relief for UK Prime Minister David Cameron to put his political woes behind him and show some love to the British insurance industry. On the day it emerged that he had s... Continue reading →
About four years ago, a key appellate court decision in Manhattan known as the “Fraser decision” (Fraser vs. 301-52 Townhouse Corp.) blocked millions of dollars in legal claims for damages rel... Continue reading →
David is an Executive Vice President & North America Practice Leader for Willis Life Sciences, based in Radnor, Pennsylvania. He has more than 17 years’ experience in insurance for the biotechnology and life sciences industries. He serves on the Board of the American Type Culture Collection, is a member of the Arthritis Foundation’s National Board of Trustees and is on the editorial board of the Pharmaceutical Outsourcing Report.
